FierceBiotech

Abbott's clearance to sell low-cost diabetes glucose monitor a sign of changing reimbursement rules

Abbott ($ABT) announced FDA clearance of its FreeStyle Precision Neo Blood Glucose Monitoring System as an over-the-counter product, and said it is the cheapest ...
Medindia

Budget-friendly Touch Screen Glucometer Gets FDA Approval, Costs Just $25

Abbott has planned to release its budget-conscious FreeStyle Precision Neo blood glucometer having received FDA clearance. The device can be purchased without a prescription and costs around $25 for ...
Medindia

Abbott Receives CE Mark for FreeStyle Optium Neo Blood Glucose and Ketone Monitoring System™

Abbott (NYSE: ABT) announced today it has received CE Marking (Conformite Europeenne) in Europe for the FreeStyle Optium Neo Blood Glucose and Ketone Monitoring System ™. The new icon-driven system ...